Josh Gottheimer
Josh Gottheimer (D-NJ) bought $1K-$15K of $CVLT (Commvault Systems, Inc. - Common Stock) on Sep 23, 2025, part of 10 transactions in this filing (6 buys, 4 sells).
HillSignal flagged 2 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
2 flagsThese flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $CVLT | Commvault Systems, Inc. - Common Stock | $1K-$15K | $191.79 | — | — | Sep 23, 2025 |
| BUY | $IRT | Independence Realty Trust, Inc. Common Stock | $1K-$15K | $17.03 | — | — | Sep 22, 2025 |
| BUY | $MTHRY | M3 INC UNSP/ADR | $1K-$15K | $8.35 | — | — | Sep 30, 2025 |
| BUY | $NTRA | Natera, Inc. - Common Stock | $1K-$15K | $179.19 | — | — | Sep 22, 2025 |
| BUY | $SSMXY | SYSMEX CORP UNSP/ASDR | $1K-$15K | $12.62 | — | — | Sep 22, 2025 |
| BUY | $TNDM | Tandem Diabetes Care, Inc. - Common Stock | $1K-$15K | $13.06 | — | — | Sep 22, 2025 |
| SELL | $DEO | Diageo plc Common Stock | $1K-$15K | $95.98 | — | — | Sep 22, 2025 |
| PARTIAL SELL | $ISRG | Intuitive Surgical, Inc. - Common Stock | $1K-$15K | $441.18 | — | — | Sep 3, 2025 |
| SELL | $BWIN | The Baldwin Insurance Group, Inc. - Class A Common Stock | $1K-$15K | $29.83 | — | — | Sep 23, 2025 |
| SELL | $TTD | The Trade Desk, Inc. - Class A Common Stock | $1K-$15K | $45.24 | — | — | Sep 11, 2025 |
Connected Legislative Activity
2 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Ensuring Patient Access to Critical Breakthrough Products Act
HR5343 would force Medicare to provide immediate 4-year coverage for FDA breakthrough devices, directly benefiting large medical device manufacturers by eliminating the current 1-3 year coverage lag. The bill passed the Ways & Means committee 37-3 but awaits floor action. Despite bearish recent price action (MDT -8.2%, ABT -11%, BDX -7.3% in 30 days), this bill represents a structural catalyst for device revenue acceleration.
Medical Device Nonvisual Accessibility Act of 2025
HR5605, the Medical Device Nonvisual Accessibility Act, is in early committee stage with zero appropriation — a compliance mandate, not a spending bill. Home medical device makers face moderate retrofit costs but no immediate revenue impact. Market data shows medtech stocks already under broad 30-day pressure (-8% to -11%), and this bill adds a minor regulatory cost layer without near-term catalyst.
Other Filings by Josh Gottheimer
Free — no credit card
Get the next Gottheimer trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.